Neddylation E1 inhibitor MLN4924 has been used in clinical trials to inactivate Cullin-RING E3 ligase (CRL), thereby interrupting protein homeostasis and subsequently leading to cancer cell death (67). The gene discussed is IL31RA; the disease is cancer.